therapeutic agents

Several integrin-targeted therapeutic agents are currently used in clinical trials for the therapy of angiogenesis related diseases.

This barrier is an obstacle in tumour treatment, as it results in inefficient uptake of therapeutic agents.

Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used of all therapeutic agents.

and methods for delivering therapeutic agents to a subject for an extended period of time using the liquid formulations.

Many therapeutic agents have been implicated in allergies in many species of animals.

In recognition of the need to develop novel therapeutic agents, the present invention provides novel histone deacetylase inhibitors.

Such oligonucleotide therapeutic agents for the new research and development.

Clinicians are encouraged to think of micronutrients not as nutritional supplements alone but also as therapeutic agents and nutraceuticals.

derived peptides and proteins have developed into mainstream therapeutic agents.

In addition, biologic pathways that could form the basis of new therapeutic agents have been identified.

Antibodies are important therapeutic agents for cancer.

As resistance to available therapeutic agents can emerge rapidly, there is a need for continued research to find new and better agents.

Biologics (therapeutic agents of biological origin)

Therapeutic Agents of Ulcerative Colitis

Analysis of therapeutic agents for 4 kinds viral infection of respiratory tract in Beijing